What is the exact mechanism of action of clarithromycin on the microbial cell?

Clarithromycin belongs to the macrolide group and has a bacteriostatic action. Its molecular target is the 50S subunit of the bacterial ribosome. The drug binds to a specific ligand within the ribosomal tunnel during the translocation phase. This blocks the transfer of the peptidyl-tRNA from the A-site to the P-site and disrupts the release of synthesized peptides from the ribosome. In mycobacterial infections, it is also thought to inhibit protein synthesis in the organism's organelles.

What specific adverse effects, aside from gastrointestinal issues, does clarithromycin cause?

Besides dyspeptic disorders, clarithromycin can cause allergic reactions and organ toxicity. Specific adverse effects include hepatotoxicity manifesting as cholestatic hepatitis and elevated plasma transaminases, as well as ototoxicity resulting in hearing impairment. With prolonged macrolide use, risks of hearing loss and cardiotoxicity have also been noted.

What is the main pharmacokinetic advantage of clarithromycin over natural macrolides?

Improved gastrointestinal absorption, stability in acidic environments, and high tissue concentrations achieved with a convenient twice-daily dosing regimen.

What is the role of clarithromycin in gastroenterology?

It is used in combination with proton pump inhibitors and amoxicillin to eradicate Helicobacter pylori in peptic ulcer disease.

Is clarithromycin an inducer or inhibitor of CYP3A4 isoenzymes?

Clarithromycin is an inhibitor of CYP3A4 / CYP3A5 isoenzymes, which is critical to consider when evaluating drug interactions.

Home › Pharmacology › Clarithromycin: Mechanism, Pharmacokinetics and Uses

Clarithromycin

For medical students2 min readUpdated 2026-10-10

Clarithromycin is a semi-synthetic antibiotic belonging to the 14-membered macrolide group. The drug is characterized by improved pharmacokinetics and a broad spectrum of antimicrobial activity, including intracellular pathogens.

Pharmacological groupSemi-synthetic 14-membered macrolides

Dosage formsTablets 0.25 g and 0.5 g

Dosing regimenOral, 0.25–0.5 g twice daily (every 12 hours)

Specific targetsH. pylori, Mycobacterium avium, atypical flora

Mechanism of Action and Pharmacokinetics

As a member of the 14-membered macrolides, clarithromycin inhibits protein synthesis in the microbial cell. Compared to the parent erythromycin, semi-synthetic clarithromycin has improved pharmacokinetic properties: it is stable in acidic environments, is excellently absorbed from the gastrointestinal tract, and food intake does not significantly affect its absorption. The drug achieves high tissue concentrations and is prescribed with a convenient dosing schedule every 12 hours (orally or intravenously).

It is important to consider the metabolic profile of the drug. Clarithromycin is a potent inhibitor of cytochrome P450 isoenzymes (CYP3A4 / CYP3A5 and CYP1A2). This accounts for its ability to cause significant drug interactions with substrates of these enzymes (cardiovascular drugs, statins, anticoagulants, and psychotropics).

Pharmacological Effects and Spectrum of Activity

The drug demonstrates pronounced high activity against intracellular pathogens (Chlamydia, Mycoplasma, Legionella). Its antimicrobial spectrum covers gram-positive cocci, causative agents of pertussis, diphtheria, and a number of specific microorganisms. Due to high tissue penetration, macrolides are used for infections of the respiratory tract, ENT organs, skin, and soft tissues.

Clinical Indications

Clarithromycin has classical indications for macrolides, as well as several unique therapeutic directions:

Respiratory tract and ENT infections: streptococcal tonsillopharyngitis, atypical pneumonias, pertussis, diphtheria.
Gastroenterology: an essential component of combination regimens for Helicobacter pylori eradication in the treatment of gastric and duodenal ulcers (in combination with proton pump inhibitors and amoxicillin).
Mycobacterial infections: treatment and prevention of opportunistic infections in HIV caused by Mycobacterium avium.
Alternative prophylaxis: year-round prophylaxis of rheumatic fever in patients with confirmed penicillin allergies.

Adverse Effects and Clinical Considerations

As a CYP3A4 inhibitor, clarithromycin can slow the metabolism of many drugs (e.g., warfarin, cardiac medications, certain psychotropics), increasing their blood concentrations and the risk of toxic effects. Adverse reactions typical of antibiotics can occur in the gastrointestinal tract and other systems. When prescribing, physicians must cross-check the patient's concomitant therapy list to avoid pharmacokinetic conflicts.

Prescription and Administration

According to prescription guidelines, the drug is available in 0.25 g and 0.5 g tablet formulations. The standard regimen involves oral administration of 0.25 g or 0.5 g twice daily (with a 12-hour interval between doses).

Mnemonic

Clari-THRO-mycin: THROw a dose every 12 hours strictly (twice daily).

Frequently asked questions

What is the exact mechanism of action of clarithromycin on the microbial cell?: Clarithromycin belongs to the macrolide group and has a bacteriostatic action. Its molecular target is the 50S subunit of the bacterial ribosome. The drug binds to a specific ligand within the ribosomal tunnel during the translocation phase. This blocks the transfer of the peptidyl-tRNA from the A-site to the P-site and disrupts the release of synthesized peptides from the ribosome. In mycobacterial infections, it is also thought to inhibit protein synthesis in the organism's organelles.
What specific adverse effects, aside from gastrointestinal issues, does clarithromycin cause?: Besides dyspeptic disorders, clarithromycin can cause allergic reactions and organ toxicity. Specific adverse effects include hepatotoxicity manifesting as cholestatic hepatitis and elevated plasma transaminases, as well as ototoxicity resulting in hearing impairment. With prolonged macrolide use, risks of hearing loss and cardiotoxicity have also been noted.
What is the main pharmacokinetic advantage of clarithromycin over natural macrolides?: Improved gastrointestinal absorption, stability in acidic environments, and high tissue concentrations achieved with a convenient twice-daily dosing regimen.
What is the role of clarithromycin in gastroenterology?: It is used in combination with proton pump inhibitors and amoxicillin to eradicate Helicobacter pylori in peptic ulcer disease.
Is clarithromycin an inducer or inhibitor of CYP3A4 isoenzymes?: Clarithromycin is an inhibitor of CYP3A4 / CYP3A5 isoenzymes, which is critical to consider when evaluating drug interactions.

Go deeper

Comparative pharmacokinetics of 14-, 15-, and 16-membered macrolides
Mechanisms of drug interactions via the cytochrome P450 system
Current Helicobacter pylori eradication regimens
Prevention and treatment of mycobacterial infections in immunodeficiencies
Cross-resistance between macrolides and ketolides (telithromycin)